MolPort-002-051-769

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 12 USDMF, 6 CEP/COS, 2 JDMF, 6 EU WC, 14 NDC API, 16 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 API Suppliers

1 API Suppliers

FINISHED DOSAGE FORMULATIONS

257 FDF Dossiers, 112 FDA Orange Book, 81 Europe, 26 Canada, 8 South Africa, 30 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 0.5MG, TABLET;ORAL - 1MG, TABLET;ORAL - 2MG, INJECTABLE;INJECTION - 2MG/ML, INJECTABLE;INJECTION - 4MG/ML

RELATED EXCIPIENT COMPANIES

1 Minakem, 5 SPI Pharma, 2 Seqens, 1 Jai Radhe Sales, 1 Chynops Pharma, 12 Gangwal Healthcare, 4 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 4 Actylis, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 12 BASF, 1 Clariant, 11 Corel Pharma Chem, 6 DFE Pharma, 1 Doshion Polyscience, 3 Finar, 5 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 1 Novo Excipients, 3 Pharmatrans-Sanaq, 3 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 7 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 2 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

60 Fillers, Diluents & Binders, 41 Coating Systems & Additives, 31 Direct Compression, 25 Disintegrants & Superdisintegrants, 24 Controlled & Modified Release, 20 Thickeners and Stabilizers, 17 Lubricants & Glidants, 17 Granulation, 15 Co-Processed Excipients, 13 Topical, 10 Taste Masking, 9 Film Formers & Plasticizers, 9 Solubilizers, 8 Chewable & Orodispersible Aids, 6 Parenteral, 5 Empty Capsules, 4 Vegetarian Capsules, 3 Rheology Modifiers, 3 API Stability Enhancers, 3 Emulsifying Agents, 2 Coloring Agents, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 20 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 106 Finished Drug Prices, 5 Annual Reports

MARKET PLACE

9 APIs, 10 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 USP, 18 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 18140 / DOSAGE - INJECTABLE;INJECTION - 2MG/ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
LORAZEPAM(UNII: O26FZP769L) (LORAZEPAM - UNII:O26FZP769L)	LORAZEPAM	2mg in 1

Inactive Ingredients

Ingredient Name	Hospira, Inc.	REMEDYREPACK INC.
BENZYL ALCOHOL(LKG8494WBH)
POLYETHYLENE GLYCOL 400(B697894SGQ)
PROPYLENE GLYCOL(6DC9Q167V3)

Drug Product Composition: MolPort-002-051-769